Gergen Mark J 4
4 · Poseida Therapeutics, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Gergen Mark J
DirectorExecutive Chairman
Transactions
- Tax Payment
Common Stock
2024-03-01$4.13/sh−34,157$141,068→ 651,291 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on March 1, 2023.